SCHEMBL2903602

SCHEMBL2903602

c1ccc2cc3cc(-c4cc5ccc6ccccc6c5c5ccccc45)ccc3cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.46
CYP1A2 P05177 3/20 0.44
ERBB2 P04626 1/20 0.44
FYN P06241 1/20 0.44
MAOA P21397 1/20 0.44
ACHE P22303 1/20 0.44
AHR P35869 1/20 0.44
NQO2 P16083 2/20 0.42
GPR84 Q9NQS5 1/20 0.41
ALDH1A1 P00352 6/20 0.40
HSD17B10 Q99714 6/20 0.40
HIF1A Q16665 4/20 0.40
TSHR P16473 3/20 0.40
HPGD P15428 3/20 0.40
CASP1 P29466 3/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12044570 0.86 GSTP1 (0.41) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL12037162 0.83 CYP1A1 (0.41) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL12037370 0.83 MIF (0.40) GSTP1CYP1A2FYNAHRGPR84
SCHEMBL3415706 0.83 GSTP1 (0.47) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL20698566 0.83 ESR1 (0.46) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL16417805 0.82 ABCG2 (0.41) CYP1A2FYNAHRGPR84ALDH1A1
SCHEMBL13170993 0.82 CA1 (0.50) GSTP1CYP1A2GPR84ALDH1A1HPGD
SCHEMBL2478286 0.82 CA1 (0.54) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL12037233 0.82 CYP1A1 (0.40) GSTP1CYP1A2ERBB2FYNMAOA
SCHEMBL17692002 0.82 TDO2 (0.57) CYP1A2ALDH1A1HPGDKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9614159-B2 Benzophenanthrene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2017-04-04 US disclosed
US-20130285029-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-10-31 US disclosed
EP-2218706-B1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO (JP) 2013-08-21 EP disclosed
US-8507106-B2 Benzophenanthrene derivative and organic electroluminescent device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2013-08-13 US disclosed
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. 2010-12-23 US disclosed
EP-2218706-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2010-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100320452-A1 BENZOPHENANTHRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE EMPLOYING THE SAME NRAS, RSU1, RAP1A GSTP1 872/4885CYP1A2 1816/4885ERBB2 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.